Baxter International Inc. (NYSE: BAX) is -24.72% lower on its value in year-to-date trading and has touched a low of $37.74 and a high of $80.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BAX stock was last observed hovering at around $38.23 in the last trading session, with the day’s gains setting it 0.14% off its average median price target of $45.00 for the next 12 months. It is also 28.94% off the consensus price target high of $54.00 offered by 15 analysts, but current levels are 4.08% higher than the price target low of $40.00 for the same period.
Currently trading at $38.37, the stock is -3.26% and -11.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.92 million and changing 0.37% at the moment leaves the stock -30.15% off its SMA200. BAX registered -51.23% loss for a year compared to 6-month loss of -35.09%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
The stock witnessed a -3.86% gain in the last 1 month and extending the period to 3 months gives it a -27.84%, and is -1.59% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.64% over the week and 2.31% over the month.
Baxter International Inc. (BAX) has around 60000 employees, a market worth around $19.86B and $15.11B in sales. Fwd P/E is 11.66. Profit margin for the company is -16.10%. Distance from 52-week low is 1.66% and -52.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-9.60%).
Baxter International Inc. (BAX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Baxter International Inc. (BAX) is a “Overweight”. 15 analysts offering their recommendations for the stock have an average rating of 2.50, where 9 rate it as a Hold and 2 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Baxter International Inc. is expected to release its quarterly report on 04/27/2023.The EPS is expected to shrink by -291.00% this year
Baxter International Inc. (BAX) Top Institutional Holders
The shares outstanding are 507.00M, and float is at 503.13M with Short Float at 0.83%.
Baxter International Inc. (BAX) Insider Activity
A total of 17 insider transactions have happened at Baxter International Inc. (BAX) in the last six months, with sales accounting for 8 and purchases happening 9 times. The most recent transaction is an insider sale by Kunzler Jacqueline, the company’s SVP, Chief Quality Officer. SEC filings show that Kunzler Jacqueline sold 3,813 shares of the company’s common stock on Feb 21 at a price of $40.50 per share for a total of $0.15 million. Following the sale, the insider now owns 16725.0 shares.
Baxter International Inc. disclosed in a document filed with the SEC on Jan 17 that Mason Jeanne K (SVP, Human Resources) sold a total of 59,477 shares of the company’s common stock. The trade occurred on Jan 17 and was made at $44.70 per share for $2.66 million. Following the transaction, the insider now directly holds 0.13 million shares of the BAX stock.
Still, SEC filings show that on Apr 05, STROUCKEN ALBERT P L (Director) disposed off 4,020 shares at an average price of $76.02 for $0.31 million. The insider now directly holds 34,127 shares of Baxter International Inc. (BAX).
Baxter International Inc. (BAX): Who are the competitors?
The company’s main competitors (and peers) include Medtronic plc (MDT) that is trading -24.79% down over the past 12 months and Stryker Corporation (SYK) that is 8.21% higher over the same period. Becton Dickinson and Company (BDX) is -5.63% down on the 1-year trading charts.
